Evidence map›Paper›PMID 40473615›Full record

ArticleNature communications2025

Viscoelastic N‑cadherin-like interactions maintain neural progenitor cell stemness within 3D matrices.

Michelle S Huang, Bauer L LeSavage, Sadegh Ghorbani, Aidan E Gilchrist, Julien G Roth, Carla Huerta-López, Esther A Mozipo, Renato S Navarro, Sarah C Heilshorn

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. "Time Is Brain" - for Cell Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michelle S HuangDepartment of Chemical Engineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1814-7786
Bauer L LeSavageDepartment of Bioengineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-4897-9436
Sadegh GhorbaniDepartment of Materials Science and Engineering, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9591-7721
Aidan E GilchristDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0003-3536-1044
Julien G RothInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-7560-3258
Carla Huerta-LópezDepartment of Materials Science and Engineering, Stanford University, Stanford, CA, USA.
Esther A MozipoDepartment of Bioengineering, Stanford University, Stanford, CA, USA.
Renato S NavarroDepartment of Materials Science and Engineering, Stanford University, Stanford, CA, USA.
Sarah C HeilshornDepartment of Materials Science and Engineering, Stanford University, Stanford, CA, USA. heilshorn@stanford.edu.ORCID http://orcid.org/0000-0002-9801-6304

Funding

Injectable Hydrogels to Deliver Gene Therapy for Myocardial InfarctR01HL151997 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2020 to 2023
$1.7M
Engineered matrix microarrays to enhance the regenerative potential of iPSC-derived endothelial cellsR01HL142718 · NHLBI · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, HUANG, NGAN F. · 2018 to 2021
$1.6M
An Engineered Bioprinting Platform to Study Neural Migration in AssembloidsR01MH137333 · NIMH · STANFORD UNIVERSITY · PI Sarah C Heilshorn · 2025 to 2026
$1.4M
Injectable Hydrogels to Protect Transplanted Cells from HypoxiaR01EB027666 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C, PLANT, GILES · 2019 to 2022
$1.4M
Engineered biomaterials to modulate cell-cell signaling for the robust expansion of stem cellsR01EB027171 · NIBIB · STANFORD UNIVERSITY · PI HEILSHORN, SARAH C · 2019 to 2022
$1.4M
Catheter-injectable system for local drug delivery after myocardial infarctK99HL169844 · NHLBI · STANFORD UNIVERSITY · PI NAVARRO, RENATO SAMUEL · 2023 to 2024
$313k
An Engineered Hydrogel Platform to Improve Neural Organoid Reproducibility for a Multi-Organoid Disease Model of 22q11.2 Deletion SyndromeF31NS132505 · NINDS · STANFORD UNIVERSITY · PI HUANG, MICHELLE S · 2023 to 2025
$113k
California Institute for Regenerative Medicine (CIRM) DISC2-13020NHLBI NIH HHS K99 HL169844NHLBI NIH HHS R01 HL142718NHLBI NIH HHS R01 HL151997NIBIB NIH HHS R01 EB027171NIBIB NIH HHS R01 EB027666NIMH NIH HHS R01 MH137333NINDS NIH HHS F31 NS132505Novo Nordisk Fonden (Novo Nordisk Foundation) NNF22OC0073507NSF | Directorate for Education & Human Resources | Division of Graduate Education (DGE) DGE-1656518NSF | Directorate for Mathematical & Physical Sciences | Division of Materials Research (DMR) DMR- 2103812NSF | ENG/OAD | Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) CBET-2033302NSF | ENG/OAD | Division of Electrical, Communications and Cyber Systems (ECCS) ECCS-2026822U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) K99-HL169844U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01-HL142718U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01-HL151997U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01-EB027171U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01-EB027666U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) F31-NS132505
6 · The paper itself

Abstract

Neural progenitor cells (NPCs) hold immense potential as therapeutic candidates for neural regeneration, and materials-based strategies have emerged as attractive options for NPC expansion. However, maintaining NPC stemness has proven challenging in vitro, due to their propensity to form cell-dense neurospheres. While neurospheres promote cell-cell interactions required for NPC stem maintenance, they also restrict oxygen transport, leading to hypoxia and limited cell expansion. To overcome these limitations, we investigate two materials-based approaches to maintain NPC stemness: 1) physical matrix remodeling within a viscoelastic, stress-relaxing hydrogel and 2) matrix-induced N-cadherin-like signaling through a cell-instructive peptide. While viscoelasticity alone is sufficient to maintain NPC stemness compared to an elastic environment, NPCs still preferentially form neurospheres. The addition of N-cadherin-like peptides promotes a distributed culture of NPCs while maintaining their stemness through cadherin-mediated signaling, ultimately exhibiting improved long-term expansion and neural differentiation. Thus, our findings reveal matrix viscoelasticity and engineered N-cadherin-like interactions as having a synergistic effect on NPC expansion and differentiation within 3D matrices.

Indexed as

CadherinsNeural Stem CellsAnimalsCell CommunicationCell Culture Techniques, Three DimensionalCell DifferentiationCell ProliferationCells, CulturedElasticityExtracellular MatrixHydrogelsMicePeptidesSignal TransductionViscosityCadherinsHydrogelsPeptides

Identifiers

PMID40473615
PMCPMC12141632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.